Viewing Study NCT00322868


Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2026-01-22 @ 4:28 PM
Study NCT ID: NCT00322868
Status: COMPLETED
Last Update Posted: 2018-02-23
First Post: 2006-05-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease
Sponsor: University Hospitals Cleveland Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CFFTI-Pio001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View